Marksans Pharma Q4 FY 26 Earnings Call Transcript Now on NSE
Marksans Pharma has published the transcript of its Q4 FY 26 earnings conference call with analysts on NSE, covering the company's audited financial results for the quarter.
Marksans Pharma has published the transcript of its Q4 FY 26 earnings conference call with analysts on NSE, covering the company's audited financial results for the quarter.
Marksans Pharma has made its Q4 FY26 investor call transcript available via NSE filing. The document covers the audited financial results presentation to analysts and institutional investors.
Analysts/Institutional Investor Meet/Con. Call Updates Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results Marksans Pharma Limited has informed the Exchang
Marksans Pharma has initiated a shareholder engagement campaign urging investors to complete KYC updations and claim pending dividends before these are transferred to the Investor Education and Protection Fund (IEPF).
Company Update Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF Campaign for KYC and other related updations and shareholders engagement to prevent transfer of unclaimed dividend to IEPF
Press Release Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Marksans Pharma to Acquire 100% of Netherlands-based QliniQ B.V., Strengthening Presence in European Markets". Marksans Pharma Limited has informed the Exchange reg
MARKSANS PHARMA Q3 FY25 Results
MARKSANS PHARMA Q2 FY25 Results
MARKSANS PHARMA Q3 FY24 Results
Quick Notification
Smart analysis of market trends
Notifications on crucial events
Alerts in the chat you already use
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."
— Aditya M., Active Trader